Lobe Sciences Ltd.

Home
Canada
Vancouver, BC
Lobe Sciences Ltd.

Building Value from Concept to Clinic Lobe Sciences currently has one line of business: Altemia, Inc. Lobe Sciences acquired Altemia® in 2023.

is a medical food (MF) company with products developed for the dietary management of sickle cell disease.

03/31/2026

Lobe Sciences’ latest update also outlines a more capital efficient operating model.

The Company described a subsidiary based structure intended to reduce parent level overhead, share scientific and administrative resources across programs, and allocate capital more efficiently as development efforts advance.

Combined with the Company’s improved financial position, this structure is intended to support disciplined ex*****on across its development programs.

Follow Lobe Sciences for ongoing corporate updates.

03/27/2026

Lobe Sciences’ latest update outlines measurable improvement in the Company’s financial position and capital structure.

Liabilities were reduced by 81%, cash increased more than 24 times, and net working capital improved by approximately $6.1 million. Outstanding warrants were also reduced by about 70%, lowering potential future dilution.

The update reflects a clearer balance sheet and a stronger financial foundation to support disciplined ex*****on.

Follow Lobe Sciences for ongoing corporate updates.

03/18/2026

Last week, Lobe Sciences announced the appointment of its new CFO.

This week’s update focuses on the broader role of financial oversight within the Company’s governance framework. Clear reporting structure, disciplined capital allocation, and consistent oversight remain important to orderly ex*****on and long term shareholder alignment.

Follow Lobe Sciences for ongoing corporate updates.

03/10/2026

Lobe Sciences Ltd. announces the appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer, effective March 2, 2026.

Mr. Rahimani has been advising management and the Board since December 1, 2025 and now assumes the role of CFO.

He brings extensive experience in financial reporting, corporate governance, corporate development, strategic transactions, and public-company compliance.

For additional information regarding this announcement or to connect with the Company, please contact the Lobe Sciences team directly.

CSE: LOBE | OTCQB: LOBEF | FWB: LOBE

03/09/2026

Lobe Sciences Ltd. will be in Miami during the upcoming Jefferies and Leerink Healthcare Conferences.

Chief Executive Officer Dr. Frederick D. Sancilio will be available for meetings with investors, pharmaceutical companies, and organizations interested in learning more about the Company’s development programs.

If you will be attending the conferences and would like to connect with the Lobe Sciences team, we welcome you to reach out to arrange a time to meet.

Will you be attending either conference this week?

03/06/2026

Lobe Sciences Ltd. will be in Miami during the upcoming Jefferies and Leerink Healthcare Conferences.

CEO Dr. Frederick D. Sancilio will be available for meetings with investors, pharmaceutical companies, and organizations interested in learning more about the Company’s development programs and pipeline.

Full announcement:
https://finance.yahoo.com/news/lobe-sciences-ltd-announces-presence-124000832.html

01/10/2026

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
Read the full press release here: https://lnkd.in/eTrwQ3SD

Address

1771 Robson Street #1641
Vancouver, BC
V6G3B7

Website

http://www.lobesciences.com/

Alerts

Be the first to know and let us send you an email when Lobe Sciences Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Lobe Sciences Ltd.:

Want your business to be the top-listed business in Vancouver?